What happens when antibiotics don’t work? Simple medical procedures and infections can become deadly. Drug-resistant diseases could cause 10 million deaths each year by 2050. Explore the Antimicrobial Resistance (AMR) Knowledge Hub for researchers, healthcare and laboratory teams in all ... Read more
New research shows COVID-19 is associated with higher risks of severe maternal and newborn complications. To provide the recommended care, we’ve created a free evidence-based eLearning course for health professionals Read more
Implementation research (IR) is critical to ensuring the safe, effective and timely rollout of the RTS,S malaria vaccine using approaches that are adapted to varying local contexts. The Access and Delivery Partnership has helped to strengthen IR capacities in Ghana ... Read more
Updated information is being provided for people and healthcare professionals on the possible risk of extremely rare and unlikely to occur specific types of blood clots following vaccination with the COVID-19 Vaccine AstraZeneca, the Medicines and Healthcare products Regulatory Agency ... Read more
EMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca). Read more
EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting of 18 March 2021. Read more
Find links to a wide variety of resources related to safety monitoring and pharmacovigilance during the COVID-19 pandemic Read more
Can't find what you're looking for? Try browsing our Featured News Sources. You can also find new previously featured on our home page in our News Archive! Read more
This module from the Toolkit for research and development of paediatric antiretroviral drugs and formulations introduces the concepts of pharmacovigilance and adverse drug reactions, discusses the burden of adverse drug reactions for children and explains the importance of pharmacovigilance in the context of antiretroviral therapy.
The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data. In order to fill the ...